|
US6890539B2
(en)
|
1998-12-22 |
2005-05-10 |
Microscience, Ltd. |
Genes and proteins, and their use
|
|
US6812021B1
(en)
|
1998-12-22 |
2004-11-02 |
Microscience Limited |
Genes and proteins and their use
|
|
US7939087B2
(en)
|
2000-10-27 |
2011-05-10 |
Novartis Vaccines And Diagnostics, Inc. |
Nucleic acids and proteins from Streptococcus groups A & B
|
|
PT1648500E
(pt)
|
2003-07-31 |
2014-10-10 |
Novartis Vaccines & Diagnostic |
Composições imunogénicas para estreptococos piogenes
|
|
US8945589B2
(en)
|
2003-09-15 |
2015-02-03 |
Novartis Vaccines And Diagnostics, Srl |
Immunogenic compositions for Streptococcus agalactiae
|
|
US7838010B2
(en)
*
|
2004-10-08 |
2010-11-23 |
Novartis Vaccines And Diagnostics S.R.L. |
Immunogenic and therapeutic compositions for Streptococcus pyogenes
|
|
EP1801235A1
(en)
*
|
2005-12-20 |
2007-06-27 |
Institut Pasteur |
Rapid detection of the "high virulent" ST-17 clone of Group B streptococcus
|
|
EP2029623A2
(en)
*
|
2006-06-19 |
2009-03-04 |
Mutabilis SA |
Identification of genes implicated in the virulence of streptococcus agalactiae
|
|
EP2063911A2
(en)
*
|
2006-07-26 |
2009-06-03 |
Novartis Ag |
Immunogenic compositions for gram positive bacteria
|
|
US8287885B2
(en)
|
2007-09-12 |
2012-10-16 |
Novartis Ag |
GAS57 mutant antigens and GAS57 antibodies
|
|
EP2135877A1
(en)
*
|
2008-06-19 |
2009-12-23 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Marker of steptococcus anginosus/Streptococcus constellatus (Moac) and uses thereof
|
|
US8147849B2
(en)
|
2009-02-20 |
2012-04-03 |
Novartis Ag |
Protective antigens for group B Streptococcus hypervirulent strains
|
|
ITMI20090946A1
(it)
|
2009-05-28 |
2010-11-29 |
Novartis Ag |
Espressione di proteine ricombinanti
|
|
WO2011008548A1
(en)
|
2009-06-29 |
2011-01-20 |
Genocea Biosciences, Inc. |
Vaccines and compositions against streptococcus pneumoniae
|
|
GB201101665D0
(en)
|
2011-01-31 |
2011-03-16 |
Novartis Ag |
Immunogenic compositions
|
|
MX344120B
(es)
|
2011-01-20 |
2016-12-06 |
Genocea Biosciences Inc |
Vacunas y composiciones contra streptococcus pneumoniae.
|
|
EP2682401A4
(en)
*
|
2011-02-02 |
2015-06-03 |
Microbial Chem Res Found |
FOR OBTAINING THE BLOOD-BRAIN-DISABLED MEDICAMENT OUTPUT MATERIAL, PEPTIDE THEREOF AND USE THEREOF
|
|
EP2557424A1
(en)
|
2011-08-11 |
2013-02-13 |
InGen Biosciences |
Method for diagnosing Streptococcus, Enterococcus and Pepstostreptococcus genera infections
|
|
WO2013124473A1
(en)
*
|
2012-02-24 |
2013-08-29 |
Novartis Ag |
Pilus proteins and compositions
|
|
MX2014011652A
(es)
*
|
2012-03-30 |
2014-10-24 |
Du Pont |
Enzimas utiles para la produccion de peracidos.
|
|
CA2896552A1
(en)
|
2012-10-03 |
2014-04-10 |
Novartis Ag |
Immunogenic compositions
|
|
US20160145591A1
(en)
*
|
2013-07-16 |
2016-05-26 |
Universite De Lausanne |
Bacterial lysins and uses thereof
|
|
JP2017523985A
(ja)
*
|
2014-08-05 |
2017-08-24 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
抗原用担体分子
|
|
PL3411389T3
(pl)
|
2016-02-04 |
2021-10-25 |
Genovis Ab |
Nowe proteazy streptokokowe
|
|
US11028159B2
(en)
|
2017-05-02 |
2021-06-08 |
Venomyx, Inc. |
Composition and methods for treating snake envenomation
|
|
WO2018237010A2
(en)
*
|
2017-06-20 |
2018-12-27 |
The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Vaccine compositions and methods of using the same
|
|
PL239045B1
(pl)
*
|
2018-01-09 |
2021-11-02 |
Inst Immunologii I Terapii Doswiadczalnej Polskiej Akademii Nauk |
Epitop specyficzny dla zakaźnych Streptococcus agalactiae oraz sposób wykrywania zakażenia pacjenta szczepem Streptococcus agalactiae
|
|
GB2597566B
(en)
*
|
2018-06-13 |
2023-02-01 |
Gen Probe Inc |
Compositions and methods for detecting group B streptococcus nucleic acid
|
|
BR122021012517A2
(pt)
|
2018-08-06 |
2021-08-10 |
Medikine, Inc. |
Ligante il-2rgamac, composto compreendendo referido ligante, composição farmacêutica e uso do referido ligante
|
|
AU2020380296A1
(en)
|
2019-11-05 |
2022-06-16 |
Medikine Inc. |
IL-2RβγC binding compounds
|
|
IL293553A
(en)
*
|
2019-12-06 |
2022-08-01 |
Theratechnologies Inc |
Conjugated compounds that bind sortilin, preparations and uses thereof for the treatment of cancer
|
|
JP2023514128A
(ja)
|
2020-02-03 |
2023-04-05 |
メディカイン、インコーポレイテッド |
ＩＬ－７Ｒαγｃ結合化合物
|
|
WO2021163584A1
(en)
*
|
2020-02-12 |
2021-08-19 |
The Broad Institute, Inc. |
Field deployable crispr-cas diagnostics and methods of use thereof
|
|
US11639523B2
(en)
|
2020-03-23 |
2023-05-02 |
The Broad Institute, Inc. |
Type V CRISPR-Cas systems and use thereof
|
|
WO2022026534A1
(en)
*
|
2020-07-28 |
2022-02-03 |
Kansas State University Research Foundation |
Sars-cov-2 immunogenic compositions and methods for protecting against sars-cov-2 clinical signs
|
|
MX2023005180A
(es)
*
|
2020-11-04 |
2023-05-15 |
Medikine Inc |
Compuestos de union a il-2r\03b2?c y usos de estos.
|
|
US11999771B2
(en)
|
2022-04-07 |
2024-06-04 |
Medikine, Inc. |
IL-7Rαγc ligand immunoglobulin fusion proteins
|
|
WO2025017062A1
(en)
*
|
2023-07-18 |
2025-01-23 |
Intervet International B.V. |
New type of streptococcus agalactiae serotype ia bacterium and vaccines thereof
|
|
TW202542195A
(zh)
*
|
2024-01-08 |
2025-11-01 |
美商得納利醫療公司 |
用於調節Ｔａｕ表現之組成物及方法
|
|
WO2025250877A1
(en)
*
|
2024-05-31 |
2025-12-04 |
Saliogen Therapeutics, Inc. |
Mobile genetic elements from myotis myotis
|